SCHEMBL14739618

SCHEMBL14739618

[CH2]CCN1CCN(c2ccc(OC)cc2)CC1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.76
HSD17B10 Q99714 1/20 0.69
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
HTR1A P08908 5/20 0.58
HTR7 P34969 2/20 0.56
HTR2A P28223 2/20 0.56
SOD1 P00441 1/20 0.56
ADRA1A P35348 1/20 0.56
SIGMAR1 Q99720 2/20 0.54
HTR3E A5X5Y0 1/20 0.54
HTR3B O95264 1/20 0.54
ADRB1 P08588 1/20 0.54
HTR3A P46098 1/20 0.54
HTR3D Q70Z44 1/20 0.54
HTR3C Q8WXA8 1/20 0.54
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54
MAPT P10636 1/20 0.54
HTT P42858 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9670409 0.88 DRD2 (0.68) DRD2HSD17B10MEN1KMT2AHTR1A
SCHEMBL5915124 0.86 DRD2 (1.00) DRD2HSD17B10MEN1KMT2AHTR1A
SCHEMBL9559845 0.85 DRD2 (0.73) DRD2HSD17B10MEN1KMT2AHTR1A
SCHEMBL19099996 0.85 DRD2 (0.73) DRD2HSD17B10MEN1KMT2AHTR1A
SCHEMBL4251574 0.85 HSD17B10 (0.82) DRD2HSD17B10MEN1KMT2AHTR1A
SCHEMBL2109825 0.85 DRD2 (0.73) DRD2HSD17B10MEN1KMT2AHTR1A
Hydrochloric Acid SCHEMBL11218267 0.85 DRD2 (0.97) DRD2HSD17B10MEN1KMT2AHTR1A
SCHEMBL18937451 0.83 DRD2 (0.82) DRD2HSD17B10MEN1KMT2AHTR1A
Hydrochloric Acid SCHEMBL11456534 0.83 DRD2 (0.71) DRD2HSD17B10MEN1KMT2AHTR1A
Hydrochloric Acid SCHEMBL11447131 0.83 DRD2 (0.71) DRD2HSD17B10MEN1KMT2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9212143-B2 Small molecule inhibitors of protein kinases LEVOLTA PHARMACEUTICALS, INC. (US) 2015-12-15 US disclosed
US-20130058980-A1 SMALL MOLECULE INHIBITORS OF PROTEIN KINASES LEVOLTA PHARMACEUTICALS, INC. 2013-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130058980-A1 SMALL MOLECULE INHIBITORS OF PROTEIN KINASES SYK, BTK, LCK DRD2 4144/4885HSD17B10 4430/4885MEN1 2031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.